Knowledge gaps, challenges, and opportunities in health and prevention research for Asian Americans, Native Hawaiians, and Pacific Islanders: a report from the …

AM Kanaya, AW Hsing, SV Panapasa… - Annals of internal …, 2022 - acpjournals.org
Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI) comprise 7.7% of
the US population, and AsA have had the fastest growth rate since 2010. Yet the National …

Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement

NR Bhakta, C Bime, DA Kaminsky… - American journal of …, 2023 - atsjournals.org
Current American Thoracic Society (ATS) standards promote the use of race and ethnicity-
specific reference equations for pulmonary function test (PFT) interpretation. There is rising …

Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk

N Shrine, AG Izquierdo, J Chen, R Packer, RJ Hall… - Nature …, 2023 - nature.com
Lung-function impairment underlies chronic obstructive pulmonary disease (COPD) and
predicts mortality. In the largest multi-ancestry genome-wide association meta-analysis of …

Pulmonary function testing

GL Ruppel, PL Enright - Respiratory care, 2012 - rc.rcjournal.com
Pulmonary function testing is often considered the basis for diagnosis in many categories of
pulmonary disease. Although most of the testing methodologies are well established and …

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary …

GT Ferguson, KF Rabe, FJ Martinez… - The Lancet …, 2018 - thelancet.com
Background Inhaled corticosteroids have been used in patients with chronic obstructive
pulmonary disease (COPD), but the potential benefits of their use in triple therapy are not …

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

P Sakornsakolpat, D Prokopenko, M Lamontagne… - Nature …, 2019 - nature.com
Chronic obstructive pulmonary disease (COPD) is the leading cause of respiratory mortality
worldwide. Genetic risk loci provide new insights into disease pathogenesis. We performed …

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised …

J Vestbo, JA Anderson, RD Brook, PMA Calverley… - The Lancet, 2016 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) often coexists with
cardiovascular disease. Treatments for airflow limitation might improve survival and both …

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

BD Hobbs, K De Jong, M Lamontagne, Y Bossé… - Nature …, 2017 - nature.com
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide.
We performed a genetic association study in 15,256 cases and 47,936 controls, with …

Race/ethnicity, spirometry reference equations, and prediction of incident clinical events: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study

A Elmaleh-Sachs, P Balte, EC Oelsner… - American journal of …, 2022 - atsjournals.org
Rationale: Normal values for FEV1 and FVC are currently calculated using cross-sectional
reference equations that include terms for race/ethnicity, an approach that may reinforce …

Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS)

D Couper, LM LaVange, ML Han, RG Barr, E Bleecker… - Thorax, 2014 - thorax.bmj.com
Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre
observational study of chronic obstructive pulmonary disease (COPD) designed to guide …